Acquired FXIII inhibitors: A systematic review

Journal of Thrombosis and Thrombolysis

Volumn 36, Issue 1, 2013, Pages 109-114

  Franchini, Massimo ^a   Frattini, Francesco ^a   Crestani, Silvia ^a   Bonfanti, Carlo ^a  

^a CARLO POMA HOSPITAL   (Italy)

Author keywords

Autoantibodies; Bleeding; Factor XIII; Inhibitors; Therapy

Indexed keywords

AUTOANTIBODY; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 ANTIBODY; BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 13 INHIBITOR; BLOOD CLOTTING INHIBITOR; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; ISONIAZID; PENICILLIN DERIVATIVE; PHENYTOIN; PRACTOLOL; PROCAINAMIDE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB; STEROID; UNCLASSIFIED DRUG;

BLEEDING; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING TEST; BLOOD SUBSTITUTION; CLINICAL FEATURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; HEMOSTASIS; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; MORTALITY; OUTCOME ASSESSMENT; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; REVIEW; SYSTEMATIC REVIEW; THROMBOSIS; WOUND HEALING IMPAIRMENT;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BLOOD COAGULATION FACTOR INHIBITORS; FACTOR XIII; FACTOR XIII DEFICIENCY; FIBRIN; HUMANS; LYMPHOPROLIFERATIVE DISORDERS;

EID: 84879221757     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0818-3     Document Type: Review

References (44)

1. Lorand L, Losowsky MS, Miloszewski KJ (1980) Human factor XIII: fibrin-stabilizing factor. Prog Hemost Thromb 5:245-290
2. Schwartz ML, Pizzo SV, Hill RL, McKee PA (1973) Human factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem 248:1395-1407
3. Koseki-Kuno S, Yamakawa M, Dickneite G, Ichinose A (2003) Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood 102:4410-4412
4. Takagi T, Doolittle RF (1974) Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. Biochemistry 13:750-756
5. Ichinose A, Davie EW (1988) Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci USA 85:5829-5833
6. Webb GC, Coggan M, Ichinose A, Board PG (1989) Localization of the coagulation factor XIII B subunit gene (F13B) to chromosome bands 1q31-32.1 and restriction fragment length polymorphism at the locus. Hum Genet 81:157-160
7. Board PG, Losowsky MS, Miloszewski KJA (1993) Factor XIII: inherited and acquired deficiency. Blood Rev 7:229-242
8. Hsieh L, Nugent D (2008) Factor XIII deficiency. Haemophilia 14:1190-1200
9. Karimi M, Bereczky Z, Cohan N, Muszbek L (2009) Factor XIII deficiency. Semin Thromb Hemost 35:426-438
10. Lorand L (2005) Factor XIII and the clotting of fibrinogen: from basic research to medicine. J Thromb Haemost 3:1337-1348
11. Ichinose A (2011) Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited. Semin Thromb Hemost 37:382-388
12. Lewis JH, Szeto IL, Ellis LD, Bayer WL (1967) An acquired inhibitor to coagulation factor 13. Johns Hopkins Med J 120:401-407
13. Lorand L, Jacobsen A, Bruner-Lorand J (1968) A pathological inhibitor of fibrin cross-linking. J Clin Investig 47:268-273
14. Godal HC (1970) An inhibitor to fibrin stabilizing factor (FSF, factor XIII). Scand J Haematol 7:43-48
15. Lorand L, Maldonado N, Fradera J, Atencio AC, Robertson B, Urayama T (1972) Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII). Br J Haematol 23:17-27
16. Lopaciuk S, Bykowska K, McDonagh JM et al (1978) Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder. J Clin Investig 61:1196-1203
17. McDevitt NB, McDonagh J, Taylor HL, Roberts HR (1972) An acquired inhibitor to factor XIII. Arch Intern Med 130:772-777
18. Graham JE, Yount WJ, Roberts HR (1973) Immunochemical characterization of a human antibody to factor XIII. Blood 41:661-669
19. Otis PT, Feinstein DI, Rapaport SI, Patch MJ (1974) An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations. Blood 44:771-781
20. Rosenberg RD, Colman RW, Lorand L (1974) A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenaemia. Br J Haematol 26:269-284
21. Milner GR, Holt PJ, Bottomley J, Maciver JE (1977) Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII. J Clin Pathol 30:770-773
22. Shires L, Gomperts ED, Bradlow BA (1979) An acquired inhibitor to factor XIII A case report. S Afr Med J 56:70-72
23. Fear JD, Miloszewski KJ, Losowsky MS (1984) An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin crosslinking. Acta Haematol 71:304-309
24. Nakamura S, Kato A, Sakata Y, Aoki N (1988) Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamide. Br J Haematol 68:313-319
25. Lorand L, Velasco PT, Rinne JR et al (1988) Autoimmune antibody (IgG Kansas) against the fibrin stabilizing (factor XIII) system. Proc Natl Acad Sci USA 85:232-236
26. Daly HM, Carson PJ, Smith JK (1991) Intracerebral haemorrhage due to acquired factor XIII inhibitor - successful response to factor XIII concentrate. Blood Coagul Fibrinolysis 2:507-514
27. Krumdieck R, Shaw DR, Huang ST, Poon MC, Rustagi PK (1991) Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenstrom's macroglobulinemia. Am J Med 90:639-645
28. Gailani D (1992) An IgG inhibitor against coagulation factor XIII: resolution of bleeding after plasma immunoadsorption with staphylococcal protein A. Am J Med 92:110-112
29. Fukue H, Anderson K, McPhedran P, Clyne L, McDonagh J (1992) A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA. Blood 79:65-74
30. Tosetto A, Rodeghiero F, Gatto E, Manotti C, Poli T (1995) An acquired hemorrhagic disorder of fibrin crosslinking due to IgG antibodies to FXIII, successfully treated with FXIII replacement and cyclophosphamide. Am J Hematol 48:34-39
31. Ahmad F, Solymoss S, Poon MC, Berube C, Sullivan AK (1996) Characterization of an acquired IgG inhibitor of coagulation factor XIII in a patient with systemic lupus erythematosus. Br J Haematol 93:700-703
32. Lorand L, Velasco PT, Murthy SN, Lefebvre P, Green D (1999) Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner. Blood 93:909-917
33. Lorand L, Velasco PT, Hill JM, Hoffmeister KJ, Kaye FJ (2002) Intracranial hemorrhage in systemic lupus erythematosus associated with an autoantibody against factor XIII. Thromb Haemost 88:919-923
34. Lim W, Moffat K, Hayward CPM (2004) Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency. J Thromb Haemost 2:1017-1019
35. Miesbach W (2005) Rituximab in the treatment of factor XIII inhibitor possibly caused by ciprofloxacin. Thromb Haemost 93:1001-1003
36. Gregory TF, Cooper B (2006) Case report of an acquired factor XIII inhibitor: diagnosis and management. Proc (Bayl Univ Med Cent) 19:221-223
37. Ajzner E, Schlammadinger A, Kerényi A et al (2009) Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood 113:723-725
38. Ishida F, Okubo K, Ito T, Okumura N, Souri M, Ichinose A (2010) Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency. Thromb Haemost 104:1284-1285
39. Luo Y, Zhang G, Zuo W, Zheng W, Dai C (2010) Acquired factor XIII inhibitor in monoclonal gammopathy of undetermined significance: characterization and cross-linked fibrin ultrastructure. Ann Hematol 89:833-834
40. Luo Y, Zhang G (2011) Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination. Haemophilia 17:393-398
41. Hayashi T, Kadohira Y, Morishita E, Asakura H, Souri M, Ichinose (2012) A case of acquired FXIII deficiency with severe bleeding symptoms. Haemophilia 18:618-620
42. Ichinose A, Souri M, Japanese collaborative research group on "Acquired haemorrha-philia due to factor XIII deficiency" (2011) As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan. Thromb Haemost 105:925-927
43. Tosetto A, Castaman G, Rodeghiero F (1993) Acquired plasma factor XIII deficiencies. Haematologica 78(Suppl. 6):5-10
44. Franchini M, Lippi G, Favaloro EJ (2012) Acquired inhibitors of coagulation factors: part II. Semin Thromb Hemost 38:447-453